Publications

5539 Results

BETA 2 microglobulin (O2M) and plasma cell labeling index (PCLI) constitute a strong prognostic index in the SWOG Intergroup transplant trial S9321: Observations on gender and age

Authors
PR Greipp;JL Jacobson;JJ Crowley;KJ Henderson;KC Anderson;RA Kyle;B Barlogie
Journal / Conference
Blood 96(11):152a(#653)
Year
2000
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)

Authors
CM Balch;SJ Soong;MI Ross;MM Urist;CP Karakousis;WJ Temple;MC Mihm;RL Barnhill;WR Jewell;HJ Wanebo;R Harrison
Journal / Conference
Annals of Surgical Oncology 7(2):87-97
Year
2000
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8393 (INT-0013)

Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17)

Authors
JM Bennett;D Catovsky;MT Daniel;G Flandrin;D Galton;HR Gralnick;CL Willman
Journal / Conference
Leukemia 14:1197-1200
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

SWOG-9035: adjuvant therapy of intermediate-thickness node-negative melanoma with an allogeneic tumor vaccine.

Authors
VK Sondak;PY Liu;RJ Tuthill;RA Kempf;JM Unger;JA Sosman;JA Thompson;GR Weiss;BG Redman;JG Jakowatz;RD Noyes;LE Flaherty
Journal / Conference
Journal of Immunotherapy 23(5):600
Year
2000
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Class I HLA serotyping in T3NO melanoma patients entered onto SWOG 9035: a phase III trial of melacine TM (allogeneic tumor lysate vaccine) vs observation.

Authors
JA Sosman;JM Unger;PY Liu;L Flaherty;J Thompson;VK Sondak
Journal / Conference
Journal of Immunotherapy 23(5):605
Year
2000
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Overview of the role of high-dose IFN (2b(HDI) in the therapy of high-risk resectable melanoma.

Authors
JM Kirkwood;JA Sosman;MS Ernstoff;MA Ross;SS Aggarawal;HF Edington
Journal / Conference
Journal of Immunotherapy 23(5):595
Year
2000
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690), SWOG-9512 (E1694)

Evolution of combined modality therapy for stage III non-small-cell lung cancer

Authors
DR Gandara;M Edelman;P Lara;P Roberts;B Leigh
Journal / Conference
Oncology 14(7)Suppl.5:35-41
Year
2000
Research Committee(s)
Lung and Melanoma
Study Number(s)
SWOG-8805, S9804

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer

Authors
SM Keller;S Adak;H Wagner;A Herskovic;R Komaki;BJ Brooks;MC Perry;RB Livingston;DH Johnson
Journal / Conference
New England Journal of Medicine 343(17):1217-1222
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)

An intervention to enhance well-being in women experiencing a breast cancer recurrence.

Authors
C Gotay;C Moinpour;K Albain;S Martino;S Green;B Taylor;J Perotti;CA Coltman, Jr.
Journal / Conference
The Department of Defense Breast Cancer Research Program 2:779
Year
2000
Research Committee(s)
Breast
Study Number(s)
S9632, S9832

Selenium effects on prostate cell growth

Authors
DG Menter;AL Sabichi;SM Lippman
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention 9:1171-1182
Year
2000
Research Committee(s)
Prevention and Epidemiology
Study Number(s)
S0000